Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Transiently Alters the Morphology of Corneal Endothelial Cells

Ripasudil (Glanatec), a selective Rho-associated coiled coil-containing protein kinase (ROCK) inhibitor, was approved in Japan in September 2014 for the treatment of glaucoma and ocular hypertension. The purpose of this study was to investigate the effect of ripasudil eye drops on corneal endothelia...

Full description

Saved in:
Bibliographic Details
Published inInvestigative ophthalmology & visual science Vol. 56; no. 12; pp. 7560 - 7567
Main Authors Okumura, Naoki, Okazaki, Yugo, Inoue, Ryota, Nakano, Shinichiro, Fullwood, Nigel J, Kinoshita, Shigeru, Koizumi, Noriko
Format Journal Article
LanguageEnglish
Published United States 01.11.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Ripasudil (Glanatec), a selective Rho-associated coiled coil-containing protein kinase (ROCK) inhibitor, was approved in Japan in September 2014 for the treatment of glaucoma and ocular hypertension. The purpose of this study was to investigate the effect of ripasudil eye drops on corneal endothelial morphology, as ROCK signaling is known to modulate the actin cytoskeleton. Morphological changes in the corneal endothelium were evaluated in human subjects by specular and slit-lamp microscopy, following topical administration of ripasudil. We also used a rabbit model to evaluate the effect of ripasudil on clinical parameters of the corneal endothelium. Twenty-four hours after ripasudil application, corneal specimens were evaluated by phalloidin staining, immunohistochemical analysis, and electron microscopy. Specular microscopy revealed morphological changes in human eyes, and slit-lamp microscopy showed guttae-like findings. The rabbit model showed morphological changes similar to those seen in human eyes after ripasudil administration. Electron microscopy demonstrated that these alterations are due to the formation of protrusions along the cell-cell borders, but this formation is transient. Expression of corneal endothelial function-related markers was not disrupted; corneal thickness and corneal volume were not changed; and no cell death was observed following ripasudil administration. Ripasudil induces transient guttae-like findings in humans, most likely due to protrusion formation along intracellular borders caused by the reduction in actomyosin contractility of the corneal endothelial cells. No severe adverse effects were observed. Physicians should be aware that ROCK inhibitors can cause these guttae-like findings, to avoid misdiagnosing patients as having Fuchs endothelial corneal dystrophy. (www.umin.ac.jp/ctr number, UMIN000018340.).
AbstractList Ripasudil (Glanatec), a selective Rho-associated coiled coil-containing protein kinase (ROCK) inhibitor, was approved in Japan in September 2014 for the treatment of glaucoma and ocular hypertension. The purpose of this study was to investigate the effect of ripasudil eye drops on corneal endothelial morphology, as ROCK signaling is known to modulate the actin cytoskeleton. Morphological changes in the corneal endothelium were evaluated in human subjects by specular and slit-lamp microscopy, following topical administration of ripasudil. We also used a rabbit model to evaluate the effect of ripasudil on clinical parameters of the corneal endothelium. Twenty-four hours after ripasudil application, corneal specimens were evaluated by phalloidin staining, immunohistochemical analysis, and electron microscopy. Specular microscopy revealed morphological changes in human eyes, and slit-lamp microscopy showed guttae-like findings. The rabbit model showed morphological changes similar to those seen in human eyes after ripasudil administration. Electron microscopy demonstrated that these alterations are due to the formation of protrusions along the cell-cell borders, but this formation is transient. Expression of corneal endothelial function-related markers was not disrupted; corneal thickness and corneal volume were not changed; and no cell death was observed following ripasudil administration. Ripasudil induces transient guttae-like findings in humans, most likely due to protrusion formation along intracellular borders caused by the reduction in actomyosin contractility of the corneal endothelial cells. No severe adverse effects were observed. Physicians should be aware that ROCK inhibitors can cause these guttae-like findings, to avoid misdiagnosing patients as having Fuchs endothelial corneal dystrophy. (www.umin.ac.jp/ctr number, UMIN000018340.).
PURPOSERipasudil (Glanatec), a selective Rho-associated coiled coil-containing protein kinase (ROCK) inhibitor, was approved in Japan in September 2014 for the treatment of glaucoma and ocular hypertension. The purpose of this study was to investigate the effect of ripasudil eye drops on corneal endothelial morphology, as ROCK signaling is known to modulate the actin cytoskeleton.METHODSMorphological changes in the corneal endothelium were evaluated in human subjects by specular and slit-lamp microscopy, following topical administration of ripasudil. We also used a rabbit model to evaluate the effect of ripasudil on clinical parameters of the corneal endothelium. Twenty-four hours after ripasudil application, corneal specimens were evaluated by phalloidin staining, immunohistochemical analysis, and electron microscopy.RESULTSSpecular microscopy revealed morphological changes in human eyes, and slit-lamp microscopy showed guttae-like findings. The rabbit model showed morphological changes similar to those seen in human eyes after ripasudil administration. Electron microscopy demonstrated that these alterations are due to the formation of protrusions along the cell-cell borders, but this formation is transient. Expression of corneal endothelial function-related markers was not disrupted; corneal thickness and corneal volume were not changed; and no cell death was observed following ripasudil administration.CONCLUSIONSRipasudil induces transient guttae-like findings in humans, most likely due to protrusion formation along intracellular borders caused by the reduction in actomyosin contractility of the corneal endothelial cells. No severe adverse effects were observed. Physicians should be aware that ROCK inhibitors can cause these guttae-like findings, to avoid misdiagnosing patients as having Fuchs endothelial corneal dystrophy. (www.umin.ac.jp/ctr number, UMIN000018340.).
Author Fullwood, Nigel J
Koizumi, Noriko
Okumura, Naoki
Okazaki, Yugo
Kinoshita, Shigeru
Inoue, Ryota
Nakano, Shinichiro
Author_xml – sequence: 1
  givenname: Naoki
  surname: Okumura
  fullname: Okumura, Naoki
  organization: Department of Biomedical Engineering Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan
– sequence: 2
  givenname: Yugo
  surname: Okazaki
  fullname: Okazaki, Yugo
  organization: Department of Biomedical Engineering Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan
– sequence: 3
  givenname: Ryota
  surname: Inoue
  fullname: Inoue, Ryota
  organization: Department of Biomedical Engineering Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan
– sequence: 4
  givenname: Shinichiro
  surname: Nakano
  fullname: Nakano, Shinichiro
  organization: Department of Biomedical Engineering Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan
– sequence: 5
  givenname: Nigel J
  surname: Fullwood
  fullname: Fullwood, Nigel J
  organization: Biomedical and Life Sciences, School of Health and Medicine, Lancaster University, Lancaster, United Kingdom
– sequence: 6
  givenname: Shigeru
  surname: Kinoshita
  fullname: Kinoshita, Shigeru
  organization: Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
– sequence: 7
  givenname: Noriko
  surname: Koizumi
  fullname: Koizumi, Noriko
  organization: Department of Biomedical Engineering Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26618648$$D View this record in MEDLINE/PubMed
BookMark eNpNkE1LxDAQhoOs6K569Co56qHaJG2aHpd1_UBFWNZzSdupjWSTmmmF_fd2_cLTvDDPvAzPjEycd0DIKYsvGZPZlfEfeMnSiGVKZXtkytKUR2mmxORfPiQzxLc45ozx-IAccimZkomaEly1Ppoj-sroHmr6YJxGoPeuNaXpfaDLLdDr4Dt6vjKdxqE29oKug3ZowPV2S-e2h4C0b4E--dC13vrXLfUNXfjgQFu6dLUft9aMeQHW4jHZb7RFOPmZR-TlZrle3EWPz7f3i_ljVCVS9VGW6brhohQ6rXNRJ3WScMarHKpUqhJyuVtJzYUsE56DYA1AxXc3iYxTpcQROf_u7YJ_HwD7YmOwGj_QDvyABcuEUiyRgo9o9I1WwSMGaIoumI0O24LFxc5zsfNcsLT48jzyZz_VQ7mB-o_-FSs-ATqtfEA
CitedBy_id crossref_primary_10_1016_j_preteyeres_2020_100863
crossref_primary_10_1097_ICO_0000000000002855
crossref_primary_10_1007_s00417_019_04283_5
crossref_primary_10_1055_a_1751_3411
crossref_primary_10_1007_s00417_024_06388_y
crossref_primary_10_1089_jop_2016_0085
crossref_primary_10_1007_s10792_019_01198_2
crossref_primary_10_22603_ssrr_2019_0019
crossref_primary_10_1080_08820538_2022_2112698
crossref_primary_10_1097_ICU_0000000000000579
crossref_primary_10_1007_s40123_023_00699_9
crossref_primary_10_1364_BOE_510432
crossref_primary_10_1007_s12325_021_02023_y
crossref_primary_10_1097_IJG_0000000000001507
crossref_primary_10_1089_jop_2018_0063
crossref_primary_10_1136_bjophthalmol_2019_315776
crossref_primary_10_1097_coa_0000000000000024
crossref_primary_10_5124_jkma_2019_62_9_497
crossref_primary_10_1002_cbic_201700547
crossref_primary_10_1007_s40266_024_01107_y
crossref_primary_10_1177_11206721231178057
crossref_primary_10_1097_ICU_0000000000000346
crossref_primary_10_3390_cells12091307
crossref_primary_10_1111_vop_12736
crossref_primary_10_1080_14656566_2017_1408791
crossref_primary_10_1007_s40265_019_01130_z
crossref_primary_10_1089_jop_2016_0028
crossref_primary_10_4103_IJO_IJO_1345_23
crossref_primary_10_1016_j_ajoc_2022_101287
crossref_primary_10_1080_13543776_2019_1653279
crossref_primary_10_1016_j_jcjo_2021_06_010
crossref_primary_10_1097_ICU_0000000000000748
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1167/iovs.15-17887
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1552-5783
EndPage 7567
ExternalDocumentID 10_1167_iovs_15_17887
26618648
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
18M
2WC
34G
39C
53G
5GY
5RE
ACGFO
ACNCT
ADBBV
AENEX
AFFNX
AFOSN
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
GROUPED_DOAJ
GX1
N9A
NPM
OK1
P2P
RHF
RPM
SJN
TR2
TRV
VH1
W8F
WH7
WOQ
WOW
X7M
ZGI
ZXP
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c468t-77adf23b3a5d93d4d44212c9ec568be963b3a6a236b429e31feec2adf24605883
ISSN 1552-5783
IngestDate Wed Jul 24 14:37:04 EDT 2024
Fri Aug 23 02:18:56 EDT 2024
Sat Sep 28 08:00:36 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c468t-77adf23b3a5d93d4d44212c9ec568be963b3a6a236b429e31feec2adf24605883
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://eprints.lancs.ac.uk/id/eprint/77062/1/i1552_5783_56_12_7560.pdf
PMID 26618648
PQID 1738814632
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1738814632
crossref_primary_10_1167_iovs_15_17887
pubmed_primary_26618648
PublicationCentury 2000
PublicationDate 2015-11-01
PublicationDateYYYYMMDD 2015-11-01
PublicationDate_xml – month: 11
  year: 2015
  text: 2015-11-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Investigative ophthalmology & visual science
PublicationTitleAlternate Invest Ophthalmol Vis Sci
PublicationYear 2015
SSID ssj0021120
Score 2.4129765
Snippet Ripasudil (Glanatec), a selective Rho-associated coiled coil-containing protein kinase (ROCK) inhibitor, was approved in Japan in September 2014 for the...
PURPOSERipasudil (Glanatec), a selective Rho-associated coiled coil-containing protein kinase (ROCK) inhibitor, was approved in Japan in September 2014 for the...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 7560
SubjectTerms Adult
Animals
Endothelium, Corneal - drug effects
Endothelium, Corneal - ultrastructure
Female
Fuchs' Endothelial Dystrophy - drug therapy
Fuchs' Endothelial Dystrophy - metabolism
Fuchs' Endothelial Dystrophy - pathology
Humans
Immunohistochemistry
Isoquinolines - administration & dosage
Male
Microscopy, Electron
Middle Aged
Ophthalmic Solutions
Rabbits
rho-Associated Kinases - antagonists & inhibitors
Sulfonamides - administration & dosage
Title Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Transiently Alters the Morphology of Corneal Endothelial Cells
URI https://www.ncbi.nlm.nih.gov/pubmed/26618648
https://search.proquest.com/docview/1738814632
Volume 56
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9swEBdZB2Nfxt7LXmgwxkZwG1u2bH8sbUe30g66FrpPRpbl2SSxgh-B9O_YH7yTZDvOtsK2L8ZItgx3P5_uTvdA6C1xmRtzTiyWxtp141kxpaFlkzTlXsLACtEBsmf0-NL9fOVdjUY_BlFLTR3v8us_5pX8D1dhDPiqsmT_gbP9ojAA98BfuAKH4fpXPD7PpNXRFxTHk7yAPQl--SyP4UctJ0drMTks5VL7CfIlq5pEuXxDU9JcZULO15N9dV5eaQX0VALVTVEmFaUhy0KXHS4SlaY1V771AzGfV0OFdlCnYyUmcpnVGZsvzBoKVau8arq8yw2IvsyaRaM7HIF4l7N8M86umWmk_a35LnvcFrLRjtfztaz7feSMzZhuHD75mqn0ziwv5dCJYXttNp_eg1rB64FR7JumNp1kNiXHOwQ6Aznre6YLwe8bAFVH0LlcVbvqKypWcvgc8G-50GhQiklATZXPXypud1O30G0HxJcKFDz8dNKb8aChTrtqrdTf2_qWqi3dvr2t6NxgvWgt5uI-uteaH3jfYOkBGoniIbpz2gZYPELVNqSwgRTuIYUBUlhBCr_vAfUBD-CEDZwwAAZv4IRlils44QGcsIbTY3T58eji4Nhq-3JY3KVBDQYZS1KHxIR5SUgSN3FVWAEPBfdoEAsQ6TBFmUNoDNqOIHYqBHfUO_oQPiBP0E4hC_EM4QAMFOaEbBry1OWpE_IwodTnUzcVzLHdMXrXETFamvIrkTZbqR8pwke2F2nCj9GbjsQRCEh16sUKIRt4wieB8nMTZ4yeGtr3S3W8en7jzAt0d4PXl2inLhvxCtTQOn6tUfET1pyMdg
link.rule.ids 315,783,787,27938,27939
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rho-Associated+Kinase+Inhibitor+Eye+Drop+%28Ripasudil%29+Transiently+Alters+the+Morphology+of+Corneal+Endothelial+Cells&rft.jtitle=Investigative+ophthalmology+%26+visual+science&rft.au=Okumura%2C+Naoki&rft.au=Okazaki%2C+Yugo&rft.au=Inoue%2C+Ryota&rft.au=Nakano%2C+Shinichiro&rft.date=2015-11-01&rft.eissn=1552-5783&rft.volume=56&rft.issue=12&rft.spage=7560&rft_id=info:doi/10.1167%2Fiovs.15-17887&rft_id=info%3Apmid%2F26618648&rft.externalDocID=26618648
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5783&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5783&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5783&client=summon